Ivan Pedrollo retweetledi

🎯Patients with a positive mpMRI (PI-RADS ≥3) but negative target & systematic biopsies still face risks of prostate cancer (26.8%) and clinically significant prostate cancer (19.3%). Follow-up strategies matter! 📈
🔹 Best outcomes: repeat mpMRIs + biopsy based on clinical/radiological triggers (96% csPCA-free at 2 yrs).
🔹 Predictors: age, prostate volume, PI-RADS score, ASAP, & biopsy core count
Tailored follow-up is essential for managing these high-risk cases. 👨⚕️📊 #ProstateCancer #mpMRI #Urology
pubmed.ncbi.nlm.nih.gov/39501078/ @EAU_YAUProstate @EAUYAUrology

English











































